Yujuan Zhang*ab,
Na Songab,
Jiamin Fuab,
Yanling Liuab,
Xuelin Zhanab,
Shanshan Pengab,
Zhi Yangab,
Xianfang Zhuc,
Yiguo Chenab,
Zhigang Wangab,
Yanrong Yuab,
Qiaofa Shia,
Yingyuan Fua,
Keng Yuanab,
Nanjin Zhouab,
Thomas E. Ichimd and
Weiping Min*abe
aInstitute of Immunotherapy and College of Basic Medicine, Nanchang University, Jiangxi Academy of Medical Sciences, Nanchang, China. E-mail: yujuanzhang@ncu.edu.cn
bJiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China
cChina-Australia Joint Laboratory for Functional Nanomaterials, School of Physics and Mechanical and Electrical Engineering, Xiamen University, Xiamen, China
dBatu Biologics Inc, San Diego, California, USA
eDepartment of Surgery, Pathology and Oncology, University of Western Ontario, London, Canada. E-mail: mweiping@uwo.ca
First published on 22nd August 2016
Correction for ‘Synergic therapy of melanoma using GNRs-MUA-PEI/siIDO2-FA through targeted gene silencing and plasmonic photothermia’ by Yujuan Zhang et al., RSC Adv., 2016, 6, 77577–77589.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2016 |